{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T15:08:04Z","timestamp":1784128084458,"version":"3.55.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81170483"],"award-info":[{"award-number":["81170483"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81230013"],"award-info":[{"award-number":["81230013"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.bbmt.2015.02.009","type":"journal-article","created":{"date-parts":[[2015,2,16]],"date-time":"2015-02-16T12:38:29Z","timestamp":1424090309000},"page":"1110-1116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Haploidentical Hematopoietic Stem Cell Transplantation without In\u00a0Vitro T Cell Depletion for the Treatment of Philadelphia Chromosome\u2013Positive Acute Lymphoblastic Leukemia"],"prefix":"10.1016","volume":"21","author":[{"given":"Huan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan-ping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-hong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-zhen","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-rong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-jun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2015.02.009_bib1","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1038\/sj.leu.2403886","article-title":"Clinical effect of imatinib added to intensive combination chemotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"19","author":"Lee","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2015.02.009_bib2","doi-asserted-by":"crossref","first-page":"4396","DOI":"10.1182\/blood-2003-08-2958","article-title":"Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate","volume":"103","author":"Thomas","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.02.009_bib3","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1200\/JCO.2005.03.2177","article-title":"High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia: a phase II study by the Japan Adult Leukemia Study Group","volume":"24","author":"Yanada","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bbmt.2015.02.009_bib4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/leu.2010.228","article-title":"Pre-transplant imatinib based therapy improves the outcome of allogeneic hematopoietic stem cell transplantation for BCR-ABL-positive acute lymphoblastic leukemia","volume":"25","author":"Mizuta","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2015.02.009_bib5","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1038\/leu.2014.30","article-title":"Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's Oncology Group study AALL0031","volume":"28","author":"Schultz","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2015.02.009_bib6","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1182\/blood.V70.2.587.587","article-title":"Bone marrow transplantation for patients with Philadelphia chromosome\u2013positive acute lymphoblastic leukemia","volume":"70","author":"Forman","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.02.009_bib7","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1182\/blood.V85.11.3353.bloodjournal85113353","article-title":"Long-term follow-up of allogeneic bone marrow recipients for Philadelphia chromosome\u2013positive acute lymphoblastic leukemia","volume":"85","author":"Chao","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.02.009_bib8","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/cncr.25690","article-title":"Philadelphia chromosome-positive acute lymphoblastic leukemia: current treatment and future perspectives","volume":"117","author":"Lee","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2015.02.009_bib9","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.1182\/blood-2009-01-199380","volume":"113","author":"Fielding","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.02.009_bib10","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1182\/blood-2005-11-4386","article-title":"Alternating versus concurrent schedules of imatinib and chemotherapy as frontline therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph1 ALL)","volume":"108","author":"Wassmann","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.02.009_bib11","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1182\/blood-2006-03-011908","article-title":"Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome\u2013positive acute lymphoblastic leukemia: results of the GRAAPH-2003 study","volume":"109","author":"de Labarthe","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.02.009_bib12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3324\/haematol.2009.011221","article-title":"Concurrent intensive chemotherapy and imatinib before and after stem cell transplantation in newly diagnosed Philadelphia chromosome\u2013positive acute lymphoblastic leukemia: final results of the CSTIBES02 trial","volume":"95","author":"Ribera","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2015.02.009_bib13","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.1200\/JCO.2010.28.1287","article-title":"Chemotherapy-phased imatinib pulses improve long-term outcome of adult patients with Philadelphia chromosome\u2013positive acute lymphoblastic leukemia: Northern Italy Leukemia Group protocol 09\/00","volume":"28","author":"Bassan","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bbmt.2015.02.009_bib14","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/sj.bmt.1705445","article-title":"Haploidentical hematopoietic stem cell transplantation without in\u00a0vitro T-cell depletion for the treatment of hematological malignancies","volume":"38","author":"Huang","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.02.009_bib15","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1038\/bmt.2012.79","article-title":"A\u00a0novel protocol for haploidentical hematopoietic SCT without in\u00a0vitro T-cell depletion in the treatment of severe acquired aplastic anemia","volume":"47","author":"Xu","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.02.009_bib16","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.bbmt.2011.08.024","article-title":"Haploidentical\/mismatched hematopoietic stem cell transplantation without in\u00a0vitro T cell depletion for T cell acute lymphoblastic leukemia","volume":"18","author":"Wang","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.02.009_bib17","first-page":"246","article-title":"Administration of imatinib in the first 90 days after allogeneic hematopoietic cell transplantation in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"124","author":"Chen","year":"2011","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.bbmt.2015.02.009_bib18","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1756-8722-5-29","article-title":"Administration of imatinib after allogeneic hematopoietic stem cell transplantation may improve disease-free survival for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"5","author":"Chen","year":"2012","journal-title":"J\u00a0Hematol Oncol"},{"issue":"1","key":"10.1016\/j.bbmt.2015.02.009_bib19","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1046\/j.1365-2559.2000.00895.x","article-title":"The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997","volume":"36","author":"Harris","year":"2000","journal-title":"Histopathology"},{"key":"10.1016\/j.bbmt.2015.02.009_bib20","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1751-553X.2007.00962.x","article-title":"Different kinetic patterns of BCR-ABL transcript levels in imatinib-treated chronic myeloid leukemia patients after achieving complete cytogenetic response","volume":"30","author":"Qin","year":"2008","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.bbmt.2015.02.009_bib21","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1038\/sj.leu.2403136","article-title":"Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using \u201creal-time\u201d quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR)\u2014a Europe against cancer program","volume":"17","author":"Beillard","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2015.02.009_bib22","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00277-010-1039-5","article-title":"Characteristics of BCR-ABL kinase domain point mutations in Chinese imatinib-resistant chronic myeloid leukemia patients","volume":"90","author":"Qin","year":"2011","journal-title":"Ann Hematol"},{"key":"10.1016\/j.bbmt.2015.02.009_bib23","article-title":"National Comprehensive Cancer Network Clinical Practice Guideline in Oncology Chronic Myelogenous Leukemia","volume":"2","year":"2005","journal-title":"Version"},{"key":"10.1016\/j.bbmt.2015.02.009_bib24","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1182\/blood-2008-03-143115","article-title":"Long-term remission of Philadelphia chromosome\u2013positive acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation from matched sibling donors: a 20-year experience with the fractionated total body irradiation\u2013etoposide regimen","volume":"112","author":"Laport","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.02.009_bib25","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S1083-8791(03)70011-1","article-title":"Predictors of relapse and overall survival in Philadelphia chromosome-positive acute lymphoblastic leukemia after transplantation","volume":"9","author":"Stirewalt","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.02.009_bib26","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.bbmt.2011.08.011","article-title":"Long-term follow-up of allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: impact of tyrosine kinase inhibitors on treatment outcomes","volume":"18","author":"Kebriaei","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.02.009_bib27","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s12253-013-9658-5","article-title":"Clinical outcome of hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph\u00a0+ ALL): experience from a single institution","volume":"20","author":"Doki","year":"2014","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.bbmt.2015.02.009_bib28","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/sj.bmt.1705148","article-title":"Myeloablative allogeneic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia in adults: significant roles of total body irradiation and chronic graft-versus-host disease","volume":"36","author":"Yanada","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.02.009_bib29","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1002\/ijc.29146","article-title":"Haploidentical hematopoietic stem cell transplantation in adults with Philadelphia-negative acute lymphoblastic leukemia: no difference in the high- and low-risk groups","volume":"136","author":"Mo","year":"2014","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bbmt.2015.02.009_bib30","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.bbmt.2010.08.023","article-title":"Superior graft-versus-leukemia effect associated with transplantation of haploidentical compared with HLA-identical sibling donor grafts for high-risk acute leukemia: an historic comparison","volume":"17","author":"Wang","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.02.009_bib31","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1038\/leu.2012.135","article-title":"Impact of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European group for blood and marrow transplantation","volume":"26","author":"Baron","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2015.02.009_bib32","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1200\/JCO.2007.11.1641","article-title":"Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after\u00a0reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival","volume":"26","author":"Valc\u00e1rcel","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bbmt.2015.02.009_bib33","first-page":"428","article-title":"Impact of graft versus host disease on outcome of allogeneic peripheral blood stem cell transplantation for leukemia","volume":"35","author":"Li","year":"2014","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"10.1016\/j.bbmt.2015.02.009_bib34","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/cncr.24155","article-title":"Dasatinib treatment for Philadelphia chromosome-positive leukemias: practical considerations","volume":"115","author":"Khoury","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2015.02.009_bib35","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1182\/blood-2007-02-073528","article-title":"Dasatinib induces rapid hematologic and cytogenetic responses in adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia with resistance or intolerance to imatinib: interim results of a phase 2 study","volume":"110","author":"Ottmann","year":"2007","journal-title":"Blood"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879115001160?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879115001160?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T22:32:39Z","timestamp":1778797959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879115001160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S1083879115001160"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2015.02.009","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Haploidentical Hematopoietic Stem Cell Transplantation without In\u00a0Vitro T Cell Depletion for the Treatment of Philadelphia Chromosome\u2013Positive Acute Lymphoblastic Leukemia","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2015.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}